Artal International Management S.A. 13D and 13G filings for Rubius Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 06:36 am Sale | 2021-12-31 | 13G | Rubius Therapeutics, Inc. RUBY | Artal International Management S.A. | 3,701,580 4.100% | -782,211 (-17.45%) | Filing |
| 2021-03-08 4:30 pm Purchase | 2021-02-26 | 13G | Rubius Therapeutics, Inc. RUBY | Artal International Management S.A. | 4,483,791 5.500% | 4,483,791 (New Position) | Filing |